NCT06203600 2026-03-17Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialNational Cancer Institute (NCI)Phase 2/3 Recruiting224 enrolled
NCT03008278 2026-02-03Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 1/2 Completed51 enrolled 20 charts